Autoantigens Discovery and Characterization in Type 1 Diabetes

Autoantigens Discovery and Characterization in Type 1 Diabetes is organized by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and would be held during Oct 31 - Nov 01, 2017 at Bethesda North Marriott Hotel and Conference Center, North Bethesda, Maryland, United States of America. The target audience for this medical event for endocrinologists.

Meeting Objectives are :
One of the goals of this workshop is to bring together investigators that use new methods and technologies to identify autoantigens and responses to them (antibodies or T-cells). Researchers with diverse expertise will share ideas and identify resources. This could help them uncover opportunities to work together to accelerate the progress of antigen/antigen response discovery and detection. The workshop also could bring in experts to advise on next steps and help discoveries transition to utility as biomarkers of disease progression, treatment response, and ultimately new antigen-specific therapeutics.

Another goal of the workshop is to have a discussion on the progress and potential future development for
• The identification of new autoantigens and epitopes in T1D.
• The characterization of the response to new and previously known antigens (T-cell or humoral).
• The use of these antigens/epitopes and their response for identifying disease triggers and mechanisms, monitoring disease progression, and developing new treatments or preventative vaccines.

Additional details will be posted as soon as they are available.